CS Diagnostics Corp. (CSDX)

CS Diagnostics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2009	FY 2008
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2009	Dec 31, 2008
Net Income	0.07	0	-0.02	-0.27	-0.4
Depreciation & Amortization	-	-	-	0	0
Other Operating Activities	0	-	-	-	0
Change in Accounts Receivable	-0.08	0.01	-	-	-
Change in Accounts Payable	0.01	0	0.03	0.3	0.01
Change in Other Net Operating Assets	-	-	-	-0.03	-0.35
Operating Cash Flow	0.01	0.01	0.01	-0	-0.73
Operating Cash Flow Growth	-42.78%	18.77%	-	-	-
Capital Expenditures	-	-	-	-	-0.01
Sale (Purchase) of Intangibles	-	-	-499.44	-	-
Investing Cash Flow	-	-	-499.44	-	-0.01
Long-Term Debt Repaid	-	-	-	-	-1.03
Total Debt Repaid	-	-	-	-	-1.03
Net Debt Issued (Repaid)	-	-	-	-	-1.03
Issuance of Common Stock	-	-	499.42	-	1.77
Financing Cash Flow	-	-	499.42	-	0.74
Miscellaneous Cash Flow Adjustments	-	-	-	-	-0
Net Cash Flow	0.01	0.01	-0.01	-0	-0
Free Cash Flow	0.01	0.01	0.01	-0	-0.74
Free Cash Flow Growth	-42.78%	18.77%	-	-	-
Free Cash Flow Margin	3.09%	9.95%	7.37%	-	-
Free Cash Flow Per Share	-	-	-	-0.00	-7.69
Levered Free Cash Flow	-0.02	-0.01	-	0.13	-0.2
Unlevered Free Cash Flow	-0.02	-0.01	-	0.13	-0.2
Change in Working Capital	-0.06	0.01	0.03	0.27	-0.33

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 18, 2026

Data Sources Report a data error